LINC01502

Across TCGA pan-cancer cohorts, LINC01502 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of LINC01502’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where LINC01502 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01502 is over-expressed in tumor, although a few such as THCA and UCEC show the opposite, repressed pattern.

LUAD, THCA, and UCEC are the cancer types where LINC01502 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01502 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	All	+0.237	<.001	6	view →
THCA	All	All	−0.555	<.001	5	view →
UCEC	All	All	−0.301	.042	2	view →
COAD	All	All	−0.145	.017	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

LINC01502–LUAD

Open the LUAD breakdown →